ESC 24: Hot Line & Late-breaking Science Video Collection

Published: 15 August 2024

  • Views:

    Views Icon 3040

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

What's hot at the ESC Congress 2024?

Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.

  • Watch our View From the Thoraxcenter series for practice-focused reviews of the most anticipated trials from interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen. 
  • For a deeper dive into key hot line clinical trial data and its applicability, host, Dr Harriette Van Spall meets with principal investigators in her Late-Breaker Discussion series.
  • View a condensed summary of the crucial takeaways from each day in our Wrap-Up series led by Dr Mirvat Alasnag.
  • Our short, bite-sized Expert Interviews with select faculty will focus on data, take-home messages for practice and the future of their field.

Get ready for a deep dive into the latest cardiology research. Our coverage of the ESC Congress is coming soon.

More from this programme

Part 1

View From the Thoraxcenter: What's Hot at ESC 24?

2 sessions
ESC Congress 2024 Hot Line Wrap Up Watch now
ESC Congress 2024 Hot Line Preview Watch now

Part 2

Daily Wrap Ups with Dr Alasnag and Dr Al-Shaibi

4 sessions
ESC Day 1 Wrap Up: New Guidelines, HELIOS-B, ABYSS & STOP-or-NOT Watch now
ESC Day 2 Wrap-Up: NOTION-3, RESHAPE-HF2, TRI.Fr & More Watch now
Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi Watch now
Day 4 Wrap-Up: OCCUPI, REC-CAGEFREE I, AEGIS-II & More Watch now

Part 3

Hot-line Discussions with Dr Harriette Van Spall

5 sessions
AβYSS: Beta Blocker Interruption After Uncomplicated MI Watch now
RHEIA: TAVR vs SAVR in Women with Severe AS Watch now
OCEANIC-AF: Asundexian Vs Apixaban in Atrial Fibrillation Watch now
SWEDEGRAFT: No-touch Vein Graft in CABG Watch now
FINEARTS-HF: Finerenone HFmEF & HFpEF Watch now

Part 4

Expert Interviews

13 sessions
Bridging the Gap in Heart Failure Guideline Implementation from a Specialist Nurse Perspective Watch now
MATTERHORN: M-TEER vs Surgery in Heart Failure Watch now
MRAs in Heart Failure Watch now
FINE-HEART: Finerenone in HF & CKD Watch now
STEEER-AF: Stroke Prevention & Rhythm Control Therapy Watch now
NOTION-3: FFR Guided PCI in TAVI Watch now
EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD Watch now
SENIOR RITA: Invasive Vs Conservative Strategy for Older Patients with MI Watch now
EARTH-STEMI: Complete Vs Culprit-Only Revascularization in Older Patients Watch now
SCOFF: Fasting vs. Non-Fasting: Impact on Cardiac Catheterization Outcomes Watch now
GUARD-AF: Atrial Fibrillation Screening to Reduce Stroke in Elderly Individuals Watch now
SHAM-PVI: Sham Study of Pulmonary Vein Isolation in Symptomatic Atrial Fibrillation Watch now
POPular PAUSE TAVI: Continuation or interruption of OAC During TAVI Watch now

Part 5

Highlights

2 sessions
3 Trials That Will Change My Practice With Dr Muthiah Vaduganathan Watch now
3 Trials That Will Change My Practice With Dr Michelle Kittleson Watch now

Part 6

Guidelines

2 sessions
New Guidelines for the Management of Atrial Fibrillation Watch now
New Guidelines for the Management of Aortic Diseases Watch now

About the episode

ESC Congress 2024 — TEER non-inferior to mitral valve surgery with regard to death, HF rehospitalisation, stroke, reintervention of LVAD at one year.

Dr Volker Rudolph (Heart and Diabetes Center NRW, DE) and Prof Stephan Baldus (University Hospital of Köln, DE) joins us in London to discuss the MATTERHORN trial (NCT02371512; University Hospital of Köln).

This multicenter, randomized controlled trial evaluated mitral valve reconstruction strategies for patients with advanced functional or ischemic mitral regurgitation. A total of 210 participants with clinically significant, predominantly functional mitral regurgitation (MR), reduced left ventricular ejection fraction (LVEF ≥ 20%), and high surgical risk were enrolled. These patients experienced persistent heart failure symptoms despite optimal medical therapy. Participants were randomly assigned to either MitraClip therapy or surgical mitral valve repair. The primary outcome was a composite endpoint of death, heart failure rehospitalization, reintervention (repeat surgery or interventional procedure), device implantation, or stroke occurring within twelve months post-intervention.

Findings showed that TEER was non-inferior to mitral valve surgery, with a favourable safety profile of TEER as compared to surgery. 

Interview Questions: 

  1. What is the background to this trial?
  2. What was the study design, eligibility criteria and outcome measures?
  3. What are the baseline characteristics of the patients?
  4. What are the key findings?
  5. Are there specific patient subgroups that benefit more from one treatment over the other?
  6. What are the take-home messages for practice?
  7. What are the next steps?


Recorded on-site at ESC Congress 2024, London.

Editors: Jordan Rance and Mirjam Boros.
Videographers: Mike Knight, Dan Brent, Oliver Miles, Tom Green, David-Ben-Harosh.

Support: This is an independent interview produced by Radcliffe Cardiology.

Faculty Biographies

Volker Rudolph

View full profile
Stephan Baldus

Stephan Baldus

Professor and Chair

Professor Baldus is a distinguished cardiologist specialising in internal medicine and intensive care. With over 27 years of experience, he currently works at the Department of Cardiology at the University Hospital Cologne.

Dr. Baldus studied medicine at the University of Ulm and the University of Hamburg. He has conducted significant research, receiving grants from notable organisations like the Max Planck Society and the German Foundation for Heart Research.

His contributions to medicine have earned him several accolades, including the Teacher of the Year Award from the University of Hamburg in 2005 and the Albert Fraenkel Award from the German Society of Cardiology in 2008. Professor Baldus has been active on various committees, including those for the German Cardiac Society and the European Society of Cardiology.

An accomplished researcher, he has published hundreds of scientific papers, focusing on topics such as pulmonary…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.